Telomere Length as a Prognostic Factor for Overall Survival in Colorectal Cancer Patients

被引:25
作者
Jia, Houjun [1 ]
Wang, Ziwei [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing 400016, Peoples R China
关键词
Colorectal cancer; Telomere length; Prognosis; CHEMOTHERAPY; PROGRESSION; EXPRESSION; BIOMARKER; CETUXIMAB; EROSION; MARKERS; GROWTH; CELLS;
D O I
10.1159/000438614
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: The stabilization of telomere length has important roles in the carcinogenesis of colorectal cancer. A systemic review and meta-analysis of published studies was performed to assess the prognostic role of telomere length in colorectal cancer. Methods: Pubmed and Embase were searched for eligible studies on the association between telomere length and overall survival in colorectal cancer patients. The pooled hazard ratio (HR) and corresponding 95% confidence intervals (95%CI) was calculated using fixed-effects or random-effects model according to the magnitude of between-study heterogeneity. Results: Seven individual studies with a total of 956 colorectal cancer patients were included. Long telomere length in cancer tissues was marginally associated with poorer overall survival (Random-effects HR = 1.85, 95% 0.90 to 3.83, P = 0.09). When using studies with adjusted estimates, long telomere length in cancer tissues was independently and significantly associated with poorer overall survival (Fixed-effects HR = 2.70, 95% 1.51 to 4.84, P = 0.001). However, short telomere length in peripheral blood leukocytes was independently and significantly associated with poorer overall survival (Fixed-effects HR = 2.01, 95% 1.46 to 2.77, P < 0.001). Conclusions: There is some evidence for telomere length as a prognostic factor for overall survival in colorectal cancer patients. More studies with large number of participants are needed to further assess the prognostic significance of telomere length in colorectal cancer patients. (C) 2016 The Author(s)
引用
收藏
页码:122 / 128
页数:7
相关论文
共 34 条
[1]   Telomere Dynamics and Aging [J].
Aubert, Geraldine .
TELOMERES IN HEALTH AND DISEASE, 2014, 125 :89-111
[2]   Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer [J].
Augustine, T. A. ;
Baig, M. ;
Sood, A. ;
Budagov, T. ;
Atzmon, G. ;
Mariadason, J. M. ;
Aparo, S. ;
Maitra, R. ;
Goel, S. .
BRITISH JOURNAL OF CANCER, 2015, 112 (02) :313-318
[3]   Vitamin D status and ill health: a systematic review [J].
Autier, Philippe ;
Boniol, Mathieu ;
Pizot, Cecile ;
Mullie, Patrick .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (01) :76-89
[4]   Toward a molecular classification of colorectal cancer: the role of telomere length [J].
Baichoo, Esha ;
Boardman, Lisa A. .
FRONTIERS IN ONCOLOGY, 2014, 4
[5]   Colorectal cancer [J].
Ballinger, Anne B. ;
Anggiansah, Clive .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7622) :715-718
[6]   Telomeres: Prognostic markers for solid tumors [J].
Bisoffi, Marco ;
Heaphy, Christopher M. ;
Griffith, Jeffrey K. .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (10) :2255-2260
[7]   Worldwide Variations in Colorectal Cancer [J].
Center, Melissa M. ;
Jemal, Ahmedin ;
Smith, Robert A. ;
Ward, Elizabeth .
CA-A CANCER JOURNAL FOR CLINICIANS, 2009, 59 (06) :366-378
[8]   Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients [J].
Chen, Y. ;
Qu, F. ;
He, X. ;
Bao, G. ;
Liu, X. ;
Wan, S. ;
Xing, J. .
ANNALS OF ONCOLOGY, 2014, 25 (04) :869-876
[9]   SOME METHODS FOR STRENGTHENING THE COMMON X2 TESTS [J].
COCHRAN, WG .
BIOMETRICS, 1954, 10 (04) :417-451
[10]   Colorectal cancer [J].
Cunningham, David ;
Atkin, Wendy ;
Lenz, Heinz-Josef ;
Lynch, Henry T. ;
Minsky, Bruce ;
Nordlinger, Bernard ;
Starling, Naureen .
LANCET, 2010, 375 (9719) :1030-1047